Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 16/20 | 0.51 |
| ▸ | BACE2 | Q9Y5Z0 | 4/20 | 0.51 |
| ▸ | CTSD | P07339 | 4/20 | 0.51 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9848654 | 0.96 | BACE1 (0.55) | BACE1BACE2CTSD | |
| SCHEMBL29387347 | 0.96 | BACE1 (0.51) | BACE1BACE2CTSD | |
| SCHEMBL29531524 | 0.93 | NTSR2 (0.45) | BACE1BACE2CTSDNTSR2NTSR1 | |
| SCHEMBL29384387 | 0.93 | NTSR2 (0.45) | BACE1BACE2CTSDNTSR2NTSR1 | |
| SCHEMBL10381547 | 0.92 | FURIN (0.48) | BACE1BACE2CTSDNTSR2NTSR1 | |
| SCHEMBL30242247 | 0.92 | GNPAT (0.49) | BACE1BACE2CTSD | |
| SCHEMBL10381550 | 0.92 | FURIN (0.48) | BACE1BACE2CTSDNTSR2NTSR1 | |
| SCHEMBL29455900 | 0.92 | NPY1R (0.46) | BACE1BACE2CTSD | |
| SCHEMBL31110645 | 0.91 | ENPEP (0.46) | BACE1 | |
| SCHEMBL30578953 | 0.90 | BACE1 (0.49) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113710807-B | Microorganisms and methods for producing oxygenates from hexoses | 布拉斯科公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-114008197-B | Metabolic engineering for simultaneous consumption of xylose and glucose to produce chemicals from second generation sugars | 布拉斯科公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-113584015-B | Formation of synthons | 新英格兰生物实验室公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-113287013-B | Method for examining ulcerative colitis and primary sclerosing cholangitis | 国立大学法人京都大学 | 2025-04-15 | — | — | CN | disclosed |
| CN-112262215-B | Chimeric vectors | 美国卫生和人力服务部 | 2025-03-18 | — | — | CN | disclosed |
| CN-114096666-B | Compositions and methods for treating heme lesions | 比姆医疗股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-114875012-B | Engineered CRISPR-Cas9 nucleases | 通用医疗公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2025029727-A2 | COMPOSITIONS, METHODS, AND SYSTEMS FOR DNA MODIFICATION | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2025-02-06 | — | — | WO | disclosed |
| CN-113614104-B | Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A | 百深公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-113655228-B | Immunoassay method for detecting cleaved high molecular weight kininogen | 武田药品工业株式会社 | 2025-01-07 | — | — | CN | disclosed |
| CN-108728477-B | Efficient transposition mutation system and construction method | 华东理工大学 | 2022-02-22 | — | — | CN | disclosed |
| CN-111358799-B | Application of ginsenoside CK as lipid-lowering and weight-losing medicine | 东北师范大学 | 2022-02-18 | — | — | CN | disclosed |
| CN-107406510-B | Prostate antigen standard substance and application thereof | 欧普科诊断有限责任公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-114045305-A | Multi-swivel subsystem | 深圳市深研生物科技有限公司 | 2022-02-15 | — | — | CN | disclosed |
| CN-114045270-A | Method for producing ginsenoside Rg1 and special engineering bacteria thereof | 中国科学院天津工业生物技术研究所 | 2022-02-15 | — | — | CN | disclosed |
| CN-107406864-B | Method for producing L-serine using genetically engineered microorganisms lacking serine degradation pathway | 化学生物有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-114015675-A | Lambda-carrageenase OUC-LuV and application thereof | 中国海洋大学 | 2022-02-08 | — | — | CN | disclosed |
| CN-114008197-A | Metabolic engineering for simultaneous consumption of xylose and glucose to produce chemicals from second generation sugars | 布拉斯科公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007637-A | Recombinant factor VIII-FC for treatment of hemophilia and low bone mineral density | 比奥维拉迪维治疗股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-111879940-B | Pulmonary tuberculosis marker and application | 中国科学院微生物研究所 | 2022-02-01 | — | — | CN | disclosed |